In India a large number of people are living below the poverty line. They are not able to afford costlier branded drugs because many a times these drugs are too expensive. Therefore, generic drugs are a preferred option. Promotion of generic medicine can effectually cut down the ‘out of pocket’ expenses. The central as well as state governments through numerous schemes have been promoting generic medicines and providing affordable generic medicine to the masses. This application aims at show all the details about the generic medical stores and medicines as per the user requirement. The real time location of the user is tracked by using GPS (Global Positioning System).Our real-time tracking management system are consists of three components, …show more content…
The situation as in developing countries like India is quite more serious than in developed countries the patient has to bear the total cost of medicine by themself for almost all medicines. At least 80% of the population has to indulge “out of pocket” expenditure in the absence of national wide health insurance coverage. According to World Health Organization (W.H.O.) one-third of the world's population, mainly in low-and middle-income countries like India continues to lack regular access to essential drugs. In the poorest parts of Africa and Asia, this price rises to over 50percent. The reasons are well known and comprise insufficient financing, deprived health care and lack of awareness about …show more content…
Medicines consume a major part of the total money spent on health care. The use of generic drugs has been steadily increasing internationally as a result of economic pressure on health care budgets. Generic drugs give the prospect for major savings in health care expenditure since they are significantly lower in price than the equivalent branded counterparts. Prescribing generic drugs or International Non- proprietary Name (INN) by doctors and request pharmacists to dispense generic drugs are often advised means for lowering the costs of health care. Generic drugs is a proven, cost-effective strategy for dropping drug expenditure. The cost of health insurance premium will also be reduced if generic medicine will be commonly prescribed by physician/doctors. Only 17 percent of the total population was found covered by health insurance at the end of March 2014 as per the Insurance Regulatory and Development Authority (IRDA). In order to address that issue, the Government of India launched the Jan Aushadhi (Medicine for the Masses) Scheme (JAS) to provide cheap generic medicines to the patients. These medicines are provided through the Jan Aushadhi stores established across the
The Orphan Drug Act of 1983 was signed for the main purpose of promoting the research, treatment, prevention and diagnosis of rare disease or condition. Here the products which are used in rare disease can be drugs, biologics and medical devices. A rare disease means any disease which affects less than 200,000 persons in the United States or one in which the manufacturer has no expectation of recovering the money from development and sales in the United States. According to this act, there are certain incentives will be provided to the manufacturers who will develop orphan drug for the rare disease and condition. Thus, this act can encourage the treatment for rare disease.
The outcome of attempting this would make it even simpler to gain a profit in the drug industry. In the author’s opinion, if the process to acquire drugs becomes simpler, then the number of individuals
In 2007 Mylan bought the rights to the EpiPen from a German company called Merck KGaA. Sense then they have increased the price of the epipen by over 550 percent in the last eight years. During these same eight years the CEO can also be seen to have a dramatic salary increase from 2.5 to 19 million - a total of 16.5 million dollars pay increase (Gerson, Madeleine). The price for a EpiPen now is around 600 dollars opposed to what it was in 2007, a measly 94 dollars. Madeleine Gerson states that, “Because of Mylan 's control of the drug market for epinephrine injections, patients have few options other than to purchase an EpiPen.” There is no generic version of the epipen, forcing people to either pay these outrageous prices or take the risk of going without one.
Right now in the United States of America, there is a monopoly that exists that involves epinephrine auto-injectors. EpiPen is the United States only supplier of these auto-injectors because other brands have suffered setbacks and failures, patent protection laws, and because there are currently no generic versions of EpiPen in the United States (Johnson). This monopoly was not a problem until Mylan bought Meda AB in 2007 (Paton). “Since Mylan bought the rights to EpiPen in 2007, it has raised the price on 15 separate occasions, bringing the current list price to $608 for a two-pack up from about $50 a pen in 2007” (Mole). This has been a price increase of more than 500%, and this shows that Mylan has been using the monopoly to its advantage.
Steven Brill’s Bitter Pill: “Why Medical Bills Are Killing Us,” by Angelina Salikhbaeva Summary: Steven Brill in the article “Bitter Pill: Why Medical Bills Are Killing Us” clarifies his opinion about the costs of healthcare services in the United States. The author writes about different stories of how families become bankrupt or unable to pay the total cost of the treatment to the US hospitals and related medical facilities. According to Steven Brill’s article, the US hospitals prescribe too much health care to patients.
We have a pharmacy that is connected to the hospital. The have a savings plan that patients can enroll for $10 annually, whereas, generics will be offered at a lowered price and brand is a little higher. With this plan, the items that are sold in the pharmacy are also discounted. Now if you are a transplant patient and are at poverty level, the social workers at our hospital will sign the patient for Medication Assistance Plan (MAP). For certain transplant medications, there is no cost to the patient.
Nowadays it seems like legal drugs are more expensive than illegal ones. This dilemma occurs because the pharmaceutical industry affects the economy significantly. Although the United States is a mixed market economy, there are instances where the economy seems like a free market economy. A free market economy allows companies to determine the prices of goods free from government intervention. The pharmaceutical industry, despite several regulations set by the food and drug administration, is a free market economy.
You are a new physician setting up your practice in a new town. You are researching the different MCOs offered in your area and are considering becoming a physician for one of these networks. You have also invited the sales representatives of several healthy plans to speak with you about the benefits of choosing their plans. Based on the above scenario, answer the following questions: • What effects would join an MCO have your clinic regarding staffing, patient volume, and financial stability?
It can be quite prevailing for individuals to have financial problems towards health coverage. Based on the Health Affairs reference, “In the last decade, health insurance premiums costs have increased by 80%... whereas 58% of Americans report they are not able to seek medical attention due to high costs” (Gary Claxton, Matthew Rae, and Nirmita Panchal, et al). Statistics also present many factors exhibiting millions of individuals facing the risk of losing their insurance. Above all, health insurance is a basic health necessity. Medical services being available to everyone will benefit the public health not only with quality, but along with quantity.
With the skyrocketing costs of the advanced medical technology and specialty pharmaceuticals, decreasing insurance reimbursement and high levels of uninsured patients, healthcare providers are required to be more cost effective in delivering their services. Some health care facilities operate under very tight budget. In 1992, Congress established 340B drug pricing program in order to provide discounted drugs for covered entities, such as “high-Medicaid public and private nonprofit hospitals, community health centers, and other safety net providers”1, to help those facilities to deliver pharmacy services to those underinsured or uninsured outpatient populations. This program is based on the agreement between the Secretary of
Some low-income patients are able to set up monthly payment plans to pay for their scripts when money is an issue. If a patient is out of a medication and has no more refills, we give them a few pills to get by while we wait on the doctor’s office. We have a free-of-charge delivery service where our delivery driver will deliver prescriptions to elderly people who have no means of transportation. It is providing legendary customer service that really sets Hy-Vee pharmacies apart from
It may surprise you that, according to the World Health Organization (WHO) and World Bank, at least 400 million people lack access to essential health services. They said, at least 6 percent of people in 37 low and middle income countries are living in poverty because they must spend the money for health. Health care services is the most importance thing that we need because it is not only for improve the health but also through individual behaviour and lifestyle choices such as quitting smoking, eating the nutritious food and living a healthy lifestyles.
DISCUSSION From the beginning, the therapist had to deal with own doubts and anxiety. The therapist had heard a lot about the psychodynamic psychotherapy but this was the first time he conduct the sessions by himself. Unlike pharmacotherapy, there is no standard clinical practice guideline or recommendation for the therapist to refer to or follow. The therapist was worried that he was unable to conduct the therapy effectively and his patient would not benefit from the therapy.
Health care cost has seen to increase gradually as years go by. This has been influenced by major factors such as political influence, emerging chronic diseases, new procedures that are coming up including the technologies being invented for treating illnesses, pricing of medicines and treatment is not regulated and when treating ailment their may arise repetition of tests or a patient gets over treated for a particular ailment. The cost of healthcare has increased due to chronic diseases such as cancer and diabetes etc. The lifestyle people are living in this generation has led to the development of diseases that are expensive to treat or has led to there being over treatment in such for a cure of a particular ailment.
Many new companies to enter the market without burden of costly tasks such as research and development, clinical trials and manufacturing of drugs. Moreover, patent expiry is one of the reasons which is offering opportunities for lower cost generic manufacturer in terms of greater market access. Additionally, the government has increased their focus on healthcare cost cutting. It is creating pressure on the authority to allow early introduction of low-cost drugs in the